Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Lexicon Pharmaceuticals and Oncothyreon

Continue Reading

Dividend Investors Set to Face Major Dividend Tax Increase in 2013

Five Star Equities Provides Stock Research on ARMOUR Residential REIT and CYS Investments

Continue Reading

End of Dividend Top Tax Rate of 15% a Major Concern for Dividend Investors in the New Year

Five Star Equities Provides Stock Research on Chimera and Hatteras Financial

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Philip Morris and Cablevision Systems

Continue Reading

Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase

Five Star Equities Provides Stock Research on Kinder Morgan and Waste Management

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Duke Energy and PPL Corporation

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Corcept Therapeutics and NPS Pharmaceuticals

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on CME Group and People-s United Financial

Continue Reading

Number of Special Dividend Payments Surge in 2012 as Companies Look to Avoid Dividend Tax Increase

Five Star Equities Provides Stock Research on The Dow Chemical Company and Leggett & Platt

Continue Reading

Special Dividend Payments in 2012 Are Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Abbott Laboratories and Tellabs

Continue Reading